# Combination Chemotherapy Plus Radiation Therapy Followed By Surgery in Treating Patients With Stage I, Stage II, or Stage III Esophageal Cancer

> **NCT00006472** · PHASE2 · TERMINATED · sponsor: **Medstar Health Research Institute** · enrollment: 4 (actual)

## Conditions studied

- Esophageal Cancer

## Interventions

- **DRUG:** carboplatin
- **DRUG:** fluorouracil
- **DRUG:** paclitaxel
- **PROCEDURE:** conventional surgery
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00006472
- **Lead sponsor:** Medstar Health Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2000-01
- **Primary completion:** 2001-11-15
- **Final completion:** 2002-09-10
- **Target enrollment:** 4 (ACTUAL)
- **Last updated:** 2020-08-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00006472

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00006472, "Combination Chemotherapy Plus Radiation Therapy Followed By Surgery in Treating Patients With Stage I, Stage II, or Stage III Esophageal Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00006472. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*